OCON Therapeutics sees great value in forming strong global partnerships to introduce innovation and products that fit
women and promote their quality of life.

In 2016, OCON Therapeutics set foot in the heart of Europe aspiring to become a leading FemTech innovator and to improve choices for women and their quality of life. In 5 short years, almost 100,000 women chose to use our IUB® BALLERINE® – an innovative, long term, reversable and non-hormonal contraception which is now available in 30 countries worldwide.

Our growth and success of the IUB® BALLERINE® Brand is attributed to the hard work and dedication of our team and our network of professional distributors.

Today, we’re conducting Phase 2 clinical trials with our follow on the product The SEAD®: a non-invasive solution for treating Abnormal Uterine Bleeding (AUB) and/or heavy menstrual bleeding with a short, safe, and effective treatment.  Current study results show encouraging drops in monthly blood loss. In the future, The SEAD® will increase the commercial opportunities for our distributors and partners, working towards becoming a global leader in women’s health.

Do you have experience with IUDs and a strong network within the women’s health field? Do you wish to enlarge your portfolio with innovative, safe, and futuristic products? get in touch with OCON Therapeutics and become our business partner!


Our products are currently distributed in 30 countries across Europe, Africa and Israel.


Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.